Dr. Gomez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-585-2031Fax+1 650-724-3395
Summary
- Carlos A Gomez, MD, is board-certified in Adult Infectious Diseases (ABIM) and Medical Microbiology (ABP-MM). Dr. Gomez joined the Infectious Diseases Division at the University of Utah in the summer of 2018. His primary focus of interest is infections in patients with weakened immune systems relating to solid-organ transplantation, Hematopoietic Stem Cell Transplantation, cancer, and drugs that suppress or modulate immune responses. Dr. Gomez also is interested in molecular diagnostics applied to the immunocompromised host. He sees patients in the immunocompromised and general ID inpatient consultation services and the Infectious Diseases outpatient clinic at the University of Utah Health Center.
Education & Training
- UPMC Medical EducationResidency, Internal Medicine, 2011 - 2014
- National University of ColombiaClass of 2006
Certifications & Licensure
- NE State Medical License 2022 - 2026
- UT State Medical License 2017 - 2024
- CA State Medical License 2014 - 2020
- PA State Medical License 2011 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Pathology Pathology - Medical Microbiology
Publications & Presentations
PubMed
- Ehrlichiosis and anaplasmosis in solid organ transplantation: A case series and review of the literature.Timothy L Jang, Sias J Scherger, Andre C Kalil, Carlos A Gomez
Diagnostic Microbiology and Infectious Disease. 2024-11-01 - activity of omadacycline against clinical isolates of.Jonathan Pham, Russell J Benefield, Natali Baker, Shane Lindblom, Nicholas Canfield
Antimicrobial Agents and Chemotherapy. 2024-05-02 - 1 citationsInfectious complications among patients receiving ibrutinib for the treatment of hematological malignancies.Kenneth Tham, Stacy Prelewicz, Sara deHoll, Deborah M Stephens, Carlos A Gomez
American Journal of Health-System Pharmacy. 2024-02-08
Press Mentions
- You’re Eligible for the Vaccine—Should You Get Your Shot?March 26th, 2021
- Doctors Say Not to Gather for Thanksgiving, but if You Must, Do These Things to Limit RiskNovember 19th, 2020
- Utah Doctors: Schedule Your Vaccine as Soon as You're EligibleMarch 18th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: